Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $24.00

Guardian Pharmacy Services (NYSE:GRDN) had its price objective boosted by research analysts at Truist Financial from $22.00 to $24.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price target indicates a potential upside of 10.09% from the stock’s previous close.

A number of other research firms have also recently commented on GRDN. Raymond James began coverage on shares of Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price target for the company. Stephens started coverage on Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price for the company.

Guardian Pharmacy Services Stock Up 3.8 %

Shares of GRDN stock traded up $0.80 during trading hours on Friday, hitting $21.80. 6,001 shares of the company were exchanged, compared to its average volume of 155,275. Guardian Pharmacy Services has a fifty-two week low of $14.16 and a fifty-two week high of $23.05.

Insider Buying and Selling at Guardian Pharmacy Services

In other Guardian Pharmacy Services news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were acquired at an average price of $14.00 per share, with a total value of $499,996.00. Following the transaction, the director now owns 35,714 shares in the company, valued at $499,996. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Institutional Trading of Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Foundry Partners LLC bought a new position in shares of Guardian Pharmacy Services in the third quarter valued at approximately $1,680,000. Royce & Associates LP purchased a new stake in Guardian Pharmacy Services in the 3rd quarter valued at $1,260,000. Stephens Inc. AR bought a new position in Guardian Pharmacy Services during the 3rd quarter valued at $189,000. Allspring Global Investments Holdings LLC purchased a new position in Guardian Pharmacy Services during the 3rd quarter worth $5,460,000. Finally, Seven Grand Managers LLC bought a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth $2,515,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.